drugset

drugset / Trial / NCT04715048

Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

NCT04715048 ↗

Phase 0 Unknown 20 enrolled University of Southern California

RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the efficacy and side effects of Botox and Jeuveau for glabellar lines.

Timeline

Start: 2021-01-01
Primary completion: 2025-05
Completion: 2025-06

Publications

Background Rzany BJ, Ascher B, Avelar RL, Bergdahl J, Bertucci V, Bodokh I, Carruthers JA, Cartier H, Delmar H, Denfeld R, Gross JE, Heckmann M, Heden P, Hilton S, Inglefield C, Ogilvie P, Sattler G, Sebastian M, Solish N, Swift A, Trevidic P. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients. Aesthet Surg J. 2020 Mar 23;40(4):413-429. doi: 10.1093/asj/sjz110.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Botulinum toxin type A	Protein / enzyme biologic	8 iu	Other
Subject	Botulinum toxin type A	Protein / enzyme biologic	10 iu	Other
Subject	PrabotulinumtoxinA	Protein / enzyme biologic	8 iu	Other
Subject	PrabotulinumtoxinA	Protein / enzyme biologic	10 iu	Other

Indications

No indication recorded.